Latest News

  • Sustaining Growth and Margin in Uncertain Macro Environment

    Tuesday, October 30, 2018
    Sustaining Growth and Margin in Uncertain Macro Environment

    Jakarta, October 30, 2018 – PT Kalbe Farma Tbk and Subsidiaries (“Kalbe” or “the Company”) today announced its third quarter of year 2018 results. Net sales grew by 3.9% to reach Rp 15,678 billion from Rp 15,090 billion in the same period in 2017

  • Kalbe: Our Sustainable Commitment for the Pharmaceutical Industry

    Wednesday, October 3, 2018
    Kalbe: Our Sustainable Commitment for the Pharmaceutical Industry

    In 2-3 October 2018, the Asia Sustainability Reporting Summit (ASRS) 2018 was held at Novotel Clarke Quay, Singapore. ASRS is the meeting point and discussion panel for all Chief Sustainability Officers, top management of Asian companies, maker of standards for sustainability reports, academics, and practitioners of sustainability reports, and other stakeholders from within or outside Asia. The ASRS that was organized by CSRWork for the 2nd time took the theme of: Sustainability Reporting: Beyond Transparency and discussed newest trends in the development of sustainability report from the perspective of investors and how to deliver a report that is trustworthy and of quality.

  • Grand Opening KALCare Depok Outlet

    Thursday, September 27, 2018
    Grand Opening KALCare Depok Outlet

    Ongkie Tedjasurja, Director of PT Kalbe Farma Tbk., inaugurated the KALCare outlet at Pesona Square Mall, Depok, 1st floor. The KALCare outlet is the 6th outlet that is established with the purpose of approaching the community especially those living in Depok area and its surrounding areas.

  • Preserving Positive Growth in a Soft Market

    Monday, April 30, 2018
    Preserving Positive Growth in a Soft Market

    Jakarta, April 30, 2018 – PT Kalbe Farma Tbk and Subsidiaries (“Kalbe” or “the Company”) today announced net sales of Rp 5,015 billion for the first quarter of 2018, an increase of 2.4% compared to the first quarter of 2017 of Rp 4,898 billion. 

  • Kalbe Collaborates with Two New Zealand Companies

    Tuesday, March 20, 2018
    Kalbe Collaborates with Two New Zealand Companies

    Kalbe Farma Tbk (Kalbe) signed a memorandum of understanding between itself and two New Zealand Companies, Fonterra and Westland Milk Products. The Memorandum of Understanding that was signed is a form of collaboration with Fonterra in the field of product nutrition quality development and collaboration of guarantee of supply of ingredients for nutritional products with Westland Milk Products.

RSS
12345Last